In the United States, roughly 3.7% of adults needed treatment for opioid use disorder in 2022, translating to millions of people struggling with opioid addiction in any given year. Globally, an estimated 60.4 million people engaged in non-medical opioid use in 2021, making opioid addiction one of the most widespread substance use challenges in the world.
How Many Americans Are Affected
The most reliable U.S. estimates come from federal health surveys and treatment data. In 2017, about 2.1 million Americans had a diagnosed opioid use disorder. By 2022, the CDC estimated that 3.7% of all U.S. adults needed opioid use disorder treatment, a figure that reflects both diagnosed cases and people who meet clinical criteria but haven’t sought help. Among those with an opioid use disorder tied to heroin or prescription painkillers in 2024, about 37% had a severe disorder while 42% had a mild one, with the remainder falling in between.
These numbers capture people across a wide spectrum: someone physically dependent on prescription painkillers after surgery, someone using heroin daily, and someone caught in a cycle of illicit fentanyl use. The common thread is a pattern of compulsive use despite harm, difficulty stopping, and often physical withdrawal symptoms when they try.
The Global Picture
Outside the United States, opioid addiction is concentrated in different forms. Of the 60.4 million people worldwide using opioids non-medically in 2021, about 31.5 million were using opiates, primarily heroin. The remaining roughly 29 million were misusing prescription opioids or synthetic alternatives. Regions like South and Southeast Asia, parts of Africa, and Eastern Europe carry heavy burdens of heroin use, while North America’s crisis increasingly centers on synthetic opioids like fentanyl.
Fentanyl Has Reshaped the Crisis
The opioid epidemic in the U.S. has gone through distinct phases. It began in the late 1990s with widespread overprescription of painkillers, shifted toward heroin as prescriptions tightened, and then entered a third wave driven by illegally manufactured fentanyl. That synthetic opioid now dominates the landscape. In 2024, fentanyl was involved in an estimated 48,422 overdose deaths, compared to 8,006 deaths involving natural or semi-synthetic opioids like oxycodone or hydrocodone.
This shift matters because fentanyl is far more potent than earlier opioids, making accidental overdose more likely and addiction harder to manage. It also means the population affected has changed. People who never had a prescription painkiller problem are encountering fentanyl in counterfeit pills or mixed into other drugs.
Who Is Most Affected
Opioid addiction cuts across every demographic group, but the burden is not evenly distributed. Overdose death patterns reveal where the crisis hits hardest. In major urban centers, Black adults aged 55 to 64 had the highest opioid overdose death rates in 2017, at 42.7 per 100,000 people. In suburban areas, white adults aged 25 to 34 faced the steepest rates, at 58.3 per 100,000. Between 2015 and 2017, overdose death rates among Black adults aged 45 to 54 in large cities more than doubled, rising from 19.3 to 41.9 per 100,000.
Synthetic opioids like fentanyl played a disproportionate role in deaths across all racial and ethnic groups, but the involvement was highest among Black Americans, where fentanyl was a factor in up to 75% of opioid overdose deaths depending on the region. Men are also affected at higher rates than women, though the gap has narrowed over time.
Overdose Deaths Are Declining
After years of relentless increases, there’s a notable shift in the mortality data. Opioid overdose deaths in the U.S. dropped from an estimated 83,140 in 2023 to 54,743 in 2024, a decrease of nearly 27%. Fentanyl-related deaths specifically fell from 76,282 to 48,422 in that same period. Heroin deaths and prescription opioid deaths also declined.
The reasons behind the drop are still being studied, but expanded access to the overdose-reversal medication naloxone, increased availability of addiction treatment, and shifts in the drug supply likely all play a role. Still, nearly 55,000 opioid deaths in a single year remains an enormous toll, higher than the annual death count from car accidents.
Most People Don’t Receive Effective Treatment
One of the starkest numbers in the opioid crisis isn’t about addiction itself but about the gap between needing help and getting it. Among U.S. adults who needed opioid use disorder treatment in 2022, only about 55% received any form of treatment at all. And only 25% received medications specifically designed for opioid addiction, which are considered the most effective approach. Even among people who did get some form of treatment, fewer than half received medication.
Medications for opioid use disorder work by reducing cravings and preventing withdrawal, which makes it far easier for someone to stabilize their life and avoid relapse. The fact that three out of four people who need these medications aren’t getting them reflects ongoing barriers: limited treatment slots, insurance gaps, stigma, and in many rural areas, a simple lack of qualified providers. This treatment gap is one of the primary reasons the crisis persists at the scale it does.
The Economic Cost
Opioid addiction carries a financial toll that extends well beyond healthcare. In 2017, the combined economic cost of opioid use disorder and fatal opioid overdose in the U.S. was estimated at $1.02 trillion. That single-year figure includes healthcare spending, substance use treatment, criminal justice costs, lost workplace productivity, and the economic value of lives lost.
Breaking it down per person makes the scale more concrete. Each case of opioid use disorder cost an estimated $221,000, with the largest portion, about $183,000, reflecting reduced quality of life. Each fatal overdose carried an estimated cost of $11.5 million, driven overwhelmingly by the economic value assigned to a life cut short. Lost productivity alone for each overdose death was valued at $1.4 million, reflecting decades of work and earning potential erased.